Carregant...
Treatment With Bevacizumab Plus Carboplatin for Recurrent Malignant Glioma
OBJECTIVE: To estimate overall survival (OS), progression-free survival (PFS), imaging responses, and toxicities of bevacizumab plus carboplatin for the treatment of recurrent malignant glioma. The secondary objective was to estimate the agreement between post-contrast T1-weighted and T2-weighted ma...
Guardat en:
| Publicat a: | Neurosurgery |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905718/ https://ncbi.nlm.nih.gov/pubmed/20559095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1227/01.NEU.0000370918.51053.BC |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|